SEC Clears Path for Merger Vote: Scilex Holding Company Sees Significant Stock Surge

**Scilex Holding Company ($SCLX) Stock Surges Over 17% as SEC Clears Path for Denali-Semnur Merger Vote in September**

In a major development, Scilex Holding Company’s stock has skyrocketed over 17% after the Securities and Exchange Commission (SEC) cleared the path for the company to hold a merger vote with Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc. The massive surge comes as a response to this positive regulatory news.

The SEC’s decision effectively paves the way for shareholders to vote on the proposed combination of the three companies in September. This move is expected to have significant implications for Scilex Holding Company ($SCLX) stock performance going forward.

Scilex, being the majority owner of Semnur Pharmaceuticals, will see its strategic outlook enhanced by this merger. The combined entity will operate under the name “Semnur Pharmaceuticals, Inc.” following a successful vote and close of the deal.

Source: coincentral.com